Skip to main content
. 2019 Oct 15;9:14792. doi: 10.1038/s41598-019-51325-3

Table 1.

Associations between maternal 25(OH)D3 concentrations in pregnancy and neurodevelopmental outcomes.

Domains Instruments Regions Levels (n) Unadjusted Minimally adjustedc Fully adjustedd
ASD symptoms CAST-5ya (coef, 95% CI) V, S, A, G Continuous (per 10 ng/mL) (1510) −0.14 (−0.29, 0.01) −0.10 (−0.25, 0.04) −0.02 (−0.17, 0.12)
<20 ng/mL (259) Reference
20–29.9 ng/mL (534) −0.23 (−0.72, 0.26) −0.25 (−0.72, 0.22) −0.14 (−0.61, 0.32)
≥30 ng/mL (717) −0.54 (−1.01, −0.07) −0.48 (−0.94, −0.02) −0.26 (−0.71, 0.19)
Social competence CPSCS-5ya (coef, 95% CI) V, S, A, G, M Continuous (per 10 ng/mL) (1481) 1.22 (0.63, 1.81) 0.97 (0.39, 1.55) 0.77 (0.19, 1.35)
<20 ng/mL (279) Reference
20–29.9 ng/mL (538) 2.09 (0.33, 3.84) 1.97 (0.24, 3.69) 1.42 (−0.29, 3.12)
≥30 ng/mL (664) 3.42 (1.72, 5.12) 2.84 (1.16, 4.52) 2.14 (0.47, 3.82)
Total behavioural problems SDQ-5ya (coef, 95% CI) G Continuous (per 10 ng/mL) (263) −0.24 (−0.78, 0.30) −0.01 (−0.53, 0.51)
<20 ng/mL (39) Reference
20–29.9 ng/mL (124) −1.65 (−3.27, −0.03) −0.90 (−2.44, 0.63)
≥30 ng/mL (100) −1.02 (−2.70, 0.65) −0.13 (−1.75, 1.48)
Total behavioural problems SDQ-8ya (coef, 95% CI) V, S, A, G Continuous (per 10 ng/mL) (1622) −0.08 (−0.32, 0.15) −0.13 (−0.37, 0.10) 0.00 (−0.23, 0.24)
<20 ng/mL (288) Reference
20–29.9 ng/mL (576) −0.44 (−1.16, 0.29) −0.51 (−1.24, 0.22) −0.31 (−1.02, 0.41)
≥30 ng/mL (758) −0.44 (−1.14, 0.26) −0.60 (−1.30, 0.11) −0.22 (−0.91, 0.48)
Total behavioural problems CBCL-8yb (IRR, 95% CI) V, S, G Continuous (per 10 ng/mL) (1206) 0.98 (0.95, 1.02) 0.98 (0.94, 1.02) 1.00 (0.96, 1.04)
<20 ng/mL (202) Reference
20–29.9 ng/mL (415) 0.86 (0.76, 0.97) 0.87 (0.77, 0.99) 0.90 (0.79, 1.01)
≥30 ng/mL (589) 0.92 (0.82, 1.04) 0.91 (0.81, 1.02) 0.96 (0.85, 1.07)
ADHD symptoms CPRS-8yb (IRR, 95% CI) V, S, A, G Continuous (per 10 ng/mL) (1622) 1.01 (0.97, 1.05) 1.00 (0.96, 1.04) 1.01 (0.97, 1.06)
<20 ng/mL (288) Reference
20–29.9 ng/mL (576) 0.93 (0.82, 1.06) 0.93 (0.81, 1.05) 0.94 (0.83, 1.07)
≥30 ng/mL (758) 0.96 (0.85, 1.09) 0.94 (0.83, 1.06) 0.98 (0.86, 1.11)
Total behavioural problems SDQ-14ya (coef, 95% CI) M Continuous (per 10 ng/mL) (198) −0.46 (−1.13, 0.21) −0.27 (−0.95, 0.41)
<20 ng/mL (34) Reference
20–29.9 ng/mL (82) −0.81 (−2.59, 0.97) −0.43 (−2.23, 1.37)
≥30 ng/mL (82) −1.13 (−2.91, 0.66) −0.64 (−2.45, 1.17)
Total behavioural problems SDQ-18ya (coef, 95% CI) M Continuous (per 10 ng/mL) (149) −0.03 (−0.80, 0.73) 0.09 (−0.69, 0.86)
<20 ng/mL (24) Reference
20–29.9 ng/mL (58) 1.11 (−0.96, 3.18) 1.48 (−0.61, 3.58)
≥30 ng/mL (67) 0.54 (−1.49, 2.57) 0.92 (−1.16, 2.99)
ADHD symptoms CPRS-18yb (IRR, 95% CI) M Continuous (per 10 ng/mL) (151) 0.96 (0.81, 1.14) 0.96 (0.80, 1.14)
<20 ng/mL (25) Reference
20–29.9 ng/mL (60) 1.45 (0.93, 2.27) 1.33 (0.84, 2.10)
≥30 ng/mL (66) 1.22 (0.79, 1.90) 1.13 (0.72, 1.77)

Domains: ADHD = Attention Deficit and Hyperactivity Disorder; ASD = Autism Spectrum Disorder. Instruments: CAST = Childhood Autism Spectrum Test; CBCL = Child Behaviour Checklist; CPRS = Conners’ Parent Rating Scale-Revised (short form); CPSCS = California Preschool Social Competence Scale; SDQ = Strengths and Difficulties Questionnaire. Regions: A = Asturias; G = Gipuzkoa; M = Menorca; S = Sabadell; V = Valencia. aLinear regression model; bNegative binomial regression model; cAdjusted for region; dAdjusted for region, maternal age, maternal education level, maternal occupation, maternal country of birth, maternal smoking during the 1st trimester of pregnancy, partner smoking at home during the 1st trimester of pregnancy. Multiple imputation and inverse probability weighting were applied. Bold = p < 0.05.